Ameriprise Financial Inc Inovio Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $66,704 - $107,391	-10,707 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $94,328 - $181,590	10,707 New	10,707 $99,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $98,455 - $148,841	-11,583 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $31,494 - $89,021	3,291 Added 39.69%	11,583 $135,000
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $24,640 - $109,362	-3,451 Reduced 29.39%	8,292 $223,000
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $21,441 - $101,377	-7,195 Reduced 37.99%	11,743 $87,000
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $502 - $948	255 Added 1.36%	18,938 $62,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $3.02 $8,200 - $12,080	4,000 Added 27.24%	18,683 $38,000
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $49,041 - $74,883	14,683 New	14,683 $55,000
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $46,123 - $72,446	-11,857 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.92 - $5.58 $37,189 - $52,937	-9,487 Reduced 44.45%	11,857 $66,000
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $82,814 - $110,135	21,344 New	21,344 $84,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $526M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.